India's bold mandate to implement QR codes on drug packaging has been hailed as a revolutionary move to combat counterfeit medicines. However, while the vision is strong, experts say the execution must become far more secure, intelligent, and inclusive—especially for small and medium-sized enterprises (SMEs).

Key Highlights

Static QR Codes Pose Risk

• Static codes can be easily copied and reused and hence are prone to counterfeiting.

• India requires dynamic QR codes that evolve and initiate real-time alerts in case of anomalies.

QR Codes Require More Robust Security Measures

• QR generation and storage should be secured similar to financial systems.

• Experts demand end-to-end encryption, isolated access, and tamper-proof protocols.

Consumer Messaging Is the First Line of Defense
Scanning a code should provide smart responses such as:

• "This product is verified."

• "This code has already been scanned."

• "Warning: This code is not in the system."

These instant messages establish consumer confidence or raise alarm.

Alerts Must Lead to Action

• Systems must not only detect, but investigate and respond.

• Suspicious scans must trigger GPS tracking and supply chain investigations to track counterfeit sources.

Multi-Layered Security Is Essential

• QR codes are insufficient.

• Secure packaging must incorporate holograms, tamper-evident labels, forensic inks, and blockchain for traceability.

Supporting SMEs to Keep Up
Whereas large pharma can afford digital infrastructure, SMEs are hindered by costs and integration of technology.
Proposed solutions are:

• Shared serialization centers

• Label-based dynamic QR systems

• Government and private partnerships for secure tech deployment

Outsourced solutions can work if rigorous vendor audits and governance are imposed.India's QR code rule presents a unique chance to fortify world pharma leadership based on integrity and innovation. However, the triumph is in executing it as well as smartly, securely, and inclusively as possible. If executed perfectly—with multiple-level security, track-and-trace in real-time, and help for all concerned industry participants—it can render bogus drugs history and trust an unavoidable part of each pharma package.